Crescent Biopharma grants 129,626 shares to three key employees
Crescent Biopharma, Inc. has awarded stock options to three non-executive employees as part of an equity inducement plan. The company, listed on Nasdaq under the ticker CBIO, granted the options to purchase a total of 129,626 shares at a fixed price per share.
The newly granted options come with a 10-year term. Each share can be bought at an exercise price of $13.21. Vesting will occur in stages, with 25% of the shares becoming available on the first anniversary of each employee's start date. The remaining 75% will vest monthly over the following 36 months, provided the employees stay with the company.
The vesting schedule ensures a gradual release of shares, encouraging employee retention. With a total of 129,626 shares now tied to performance and tenure, the awards reflect Crescent Biopharma's approach to aligning staff interests with company growth. The shares will remain subject to the company's ongoing service conditions.
